Hide Board Information

Show Board Information

Advent Software ADVS

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/23/2021 6:23:53 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Advent Software (NASDAQ: ADVS) Stock Message Board

1. ADVS Company Profile

    

2. ADVS Time & Sales

    

3. ADVS Recent News

    

4. ADVS Filings

    

5. ADVS Financials

    

6. ADVS Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

4	ADVS 44.21 Advent Software $ADVS stock added to	clayton	03/19/2015 10:48:11 AM
3	ADVS up +0.07% percent Today $ADVS Stock High is	Lucky Jimmy	03/10/2015 1:43:58 PM
2	Latest Advent Software (ADVS) Headlines	Stock_Tracker	03/13/2014 4:51:36 AM
1	ADVS Stock Charts Last: -0.08 Thursday, February	chartguy89	02/27/2014 1:09:05 PM

Newer

Recent Articles

• Aspocomp's Strong Performance in H1 2025: Revenue Growth
• Vitrolife AB's Remarkable Growth in Consumables for Q2
• Exploring ASSA ABLOY's Robust Q2 2025 Financial Performance
• Sivers Semiconductors Reports Strong Q2 2025 Financial Performance
• Vitrolife AB Sees Steady Growth Amid Currency Challenges
• ASSA ABLOY Q2 2025 Financial Results and Growth Highlights
• ASSA ABLOY Delivers Impressive Results Despite Challenges
• Operational Insights and Future Growth of Havila Kystruten AS
• Pharming Group Prepares to Share Business Performance Insights
• ICG Enterprise Trust Buys Back Shares Amid Market Conditions
• Equinor ASA Enhances Employee Participation Through Share Buy-Back
• Exploring the Splendid Design of Honka Kömmeli Log Homes
• Insights from AS Tallink Grupp's Upcoming Investor Webinar
• Explore AS Tallink Grupp's Upcoming Investor Webinar Insights
• Aspocomp Reports Strong Growth in Half-Year Results
• Nicox and Kowa Forge Major Collaboration in Glaucoma Care
• Aalberts N.V. Expands HVAC Solutions with Geo-Flo Acquisition
• Nvidia Surpasses Global economic Leaders in Stock Index
• Volvo Group Reports Adjustments Amid Stabilizing Markets
• Hansa Biopharma's Financial Updates: Q2 2025 Highlights
• GC Biopharma's BARYCELA Secures Marketing Authorization
• Reju Partners with Circle-8 for Sustainable Textile Recycling
• Reju and Circle-8 Join Forces to Revolutionize Textile Recycling
• Dev Technosys Recognized Among Premier Mobile App Developers
• Crown LNG Faces Over 55% Drop After Delisting Announcement
• Essity's Q2 2025 Report: Challenges and Growth Ambitions
• Volvo Cars Q2 2025 EBIT Report and Future Outlook on Growth
• Publicis Groupe's Financial Journey in H1 2025 Explained
• Volvo Group Reports Q2 2025 Financial Performance Insights
• Hansa Biopharma Shows Strong Financial Growth in Q2 2025
• EQT AB Reports Impressive Half-Year Performance Analysis
• Hansa Biopharma's Q2 Report: Growth and Future Prospects
• Publicis Groupe's Impressive Financial Performance in 2025
• Viridien Prepares for Q2 2025 Financial Results Announcement
• Nicox and Kowa Forge €191.5 Million Partnership for NCX 470
• Aalberts N.V.'s Strategic Acquisition of Geo-Flo Corporation
• Volvo Cars' Q2 2025 Results Showcase Positive Change
• Telenor Group Divests Allente Stake to Viaplay Group
• Opendoor's Stocks Surge on Exciting Activist Investor Moves
• Essity Reports Strong Performance Amid Economic Challenges
• Hexaware's Strategic Move to Enhance Global Capability Centers
• Essity Reports Positive Growth Amid Economic Challenges
• Verkkokauppa.com Oyj Reports Growth Amid Market Uncertainty
• Hexagon Purus Reports Drop in Q2 2025 Revenue and Outlook
• Sanofi Extends Tender Offer for Blueprint Medicines Shares
• Novartis Achieves Strong Q2 Growth with Enhanced Guidance for 2025
• EfTEN United Property Fund Shows Steady Growth and Performance
• TGS Reports Second Quarter 2025 Financial Performance Insights
• TGS ASA Declares Quarterly Dividend for Third Quarter 2025
• Mukul Mehta Takes Helm as CFO of Novartis Amid Leadership Shift